Search

Your search keyword '"Krumholz, Harlan M."' showing total 2,271 results

Search Constraints

Start Over You searched for: Author "Krumholz, Harlan M." Remove constraint Author: "Krumholz, Harlan M." Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
2,271 results on '"Krumholz, Harlan M."'

Search Results

2. Distinguishing features of long COVID identified through immune profiling

13. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

14. Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort

15. The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID

17. Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study

18. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America

20. Association of Neighborhood-Level Marginalization With Health Care Use and Clinical Outcomes Following Hospital Discharge in Patients Who Underwent Coronary Catheterization for Acute Myocardial Infarction in a Single-Payer Health Care System

24. Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images

28. Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes

34. A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations

37. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications.

41. Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review

48. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

49. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study

50. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity

Catalog

Books, media, physical & digital resources